Hyperion DeFi Purchases Additional $5 Million in HYPE for Kinetiq iHYPE Strategy
Hyperion DeFi (NASDAQ: HYPD) has acquired an additional 108,594 HYPE tokens for $5 million, bringing its total holdings to 1,535,772 HYPE at an average price of $36.14 per token. The purchase supports the company's participation in Kinetiq's iHYPE institutional liquid staking program.
The company will utilize iHYPE, a gated smart contract environment for institutional participants, to earn passive staking yield and unlock capital efficiency. As the first public company to use Kinetiq's institutional-grade liquid staking solution, Hyperion DeFi aims to leverage opportunities on the Hyperliquid blockchain.
The company will host an investor webinar on July 29th, 2025, at 2:00pm ET to discuss its transformation from an ophthalmic tech company to a publicly listed firm focused on HYPE token treasury building.
Hyperion DeFi (NASDAQ: HYPD) ha acquisito ulteriori 108.594 token HYPE per 5 milioni di dollari, portando il totale delle sue partecipazioni a 1.535.772 HYPE ad un prezzo medio di 36,14 dollari per token. L'acquisto supporta la partecipazione dell'azienda al programma istituzionale di staking liquido iHYPE di Kinetiq.
L'azienda utilizzerà iHYPE, un ambiente smart contract riservato ai partecipanti istituzionali, per ottenere rendimenti passivi dallo staking e migliorare l'efficienza del capitale. Essendo la prima società quotata pubblicamente ad adottare la soluzione di staking liquido di livello istituzionale di Kinetiq, Hyperion DeFi punta a sfruttare le opportunità sulla blockchain Hyperliquid.
L'azienda terrà un webinar per investitori il 29 luglio 2025, alle 14:00 ET per illustrare la sua trasformazione da società tecnologica oftalmica a impresa quotata in borsa focalizzata sulla costruzione del tesoro di token HYPE.
Hyperion DeFi (NASDAQ: HYPD) ha adquirido 108,594 tokens HYPE adicionales por 5 millones de dólares, aumentando su tenencia total a 1,535,772 HYPE a un precio promedio de 36.14 dólares por token. Esta compra respalda la participación de la empresa en el programa institucional de staking líquido iHYPE de Kinetiq.
La compañía utilizará iHYPE, un entorno de contratos inteligentes restringido para participantes institucionales, para obtener rendimientos pasivos por staking y mejorar la eficiencia del capital. Como la primera empresa pública en usar la solución de staking líquido de nivel institucional de Kinetiq, Hyperion DeFi busca aprovechar oportunidades en la blockchain Hyperliquid.
La empresa realizará un seminario web para inversores el 29 de julio de 2025 a las 2:00 pm ET para hablar sobre su transformación de una compañía tecnológica oftálmica a una firma pública enfocada en la acumulación de tesorería con tokens HYPE.
Hyperion DeFi (NASDAQ: HYPD)는 500만 달러에 추가로 108,594 HYPE 토큰을 매입하여 총 보유량을 1,535,772 HYPE로 늘렸으며, 토큰당 평균 가격은 36.14달러입니다. 이번 매입은 Kinetiq의 iHYPE 기관용 리퀴드 스테이킹 프로그램 참여를 지원합니다.
회사는 기관 참가자를 위한 제한된 스마트 계약 환경인 iHYPE를 활용해 수동적인 스테이킹 수익을 얻고 자본 효율성을 높일 예정입니다. Kinetiq의 기관급 리퀴드 스테이킹 솔루션을 사용하는 최초의 상장 기업인 Hyperion DeFi는 Hyperliquid 블록체인에서 기회를 확대하려 합니다.
회사는 2025년 7월 29일 오후 2시(동부시간)에 투자자 웨비나를 개최하여 안과 기술 회사에서 HYPE 토큰 재무 구축에 집중하는 상장사로의 변모를 논의할 예정입니다.
Hyperion DeFi (NASDAQ : HYPD) a acquis 108 594 tokens HYPE supplémentaires pour 5 millions de dollars, portant son total à 1 535 772 HYPE à un prix moyen de 36,14 dollars par token. Cet achat soutient la participation de l'entreprise au programme institutionnel de staking liquide iHYPE de Kinetiq.
L'entreprise utilisera iHYPE, un environnement de contrats intelligents réservé aux participants institutionnels, pour générer des rendements passifs via le staking et améliorer l'efficacité du capital. Première société cotée à utiliser la solution de staking liquide de qualité institutionnelle de Kinetiq, Hyperion DeFi vise à exploiter les opportunités sur la blockchain Hyperliquid.
L'entreprise organisera un webinaire pour investisseurs le 29 juillet 2025 à 14h00 ET pour présenter sa transformation d'une société technologique ophtalmique à une entreprise cotée en bourse axée sur la constitution d'un trésor de tokens HYPE.
Hyperion DeFi (NASDAQ: HYPD) hat weitere 108.594 HYPE-Token für 5 Millionen US-Dollar erworben und erhöht damit seinen Gesamtbestand auf 1.535.772 HYPE bei einem durchschnittlichen Preis von 36,14 US-Dollar pro Token. Der Kauf unterstützt die Teilnahme des Unternehmens am institutionellen Liquid Staking-Programm iHYPE von Kinetiq.
Das Unternehmen wird iHYPE nutzen, eine geschützte Smart-Contract-Umgebung für institutionelle Teilnehmer, um passive Staking-Erträge zu erzielen und die Kapitaleffizienz zu steigern. Als erstes börsennotiertes Unternehmen, das Kinetiqs Liquid Staking-Lösung in institutioneller Qualität einsetzt, will Hyperion DeFi Chancen auf der Hyperliquid-Blockchain nutzen.
Das Unternehmen veranstaltet am 29. Juli 2025 um 14:00 Uhr ET ein Webinar für Investoren, um seine Transformation von einem ophthalmologischen Technologieunternehmen hin zu einer börsennotierten Firma mit Fokus auf den Aufbau eines HYPE-Token-Treasury zu erläutern.
- Strategic acquisition of 108,594 HYPE tokens expands total holdings to 1,535,772 HYPE
- First public company to utilize Kinetiq's institutional-grade liquid staking solution
- Potential for passive staking yield and capital efficiency through iHYPE
- Participation in Kinetiq's kPoints incentive program for ecosystem growth
- Significant capital allocation to volatile crypto assets
- Major business model pivot from ophthalmic tech to crypto investments
- Regulatory and compliance risks associated with DeFi operations
Insights
Hyperion DeFi expands HYPE token position to 1.5M tokens for institutional staking strategy, signaling commitment to blockchain diversification.
Hyperion DeFi has strategically acquired an additional
The company is implementing a multi-faceted strategy that combines passive staking yield with capital efficiency benefits. By utilizing the iHYPE Liquid Staking Token (LST), Hyperion gains both yield-generating exposure to HYPE while maintaining liquidity options through collateralization opportunities on HyperEVM or with offchain partners.
This move represents a significant pivot for Hyperion, which is transforming from a digital ophthalmic technology company into the first publicly-listed U.S. firm focused on building a treasury around HYPE tokens. The company is positioning itself as an institutional pioneer in the Hyperliquid ecosystem through their validator launch and participation in Kinetiq's kPoints incentive program.
What makes this development particularly noteworthy is Hyperion's status as the first public company to utilize Kinetiq's institutional-grade liquid staking solution. This creates a unique market position while potentially establishing a blueprint for public company participation in DeFi protocols. The strategic alignment with Kinetiq's future Exchange-as-a-Service ambitions suggests Hyperion is building a long-term position in the Hyperliquid ecosystem rather than making a speculative token investment.
Increases total holdings to 1,535,772 HYPE
Company to host investor webinar on Tuesday, July 29th at 2:00pm ET
LAGUNA HILLS, Calif., July 28, 2025 (GLOBE NEWSWIRE) -- Hyperion DeFi, Inc. (NASDAQ: HYPD) (“Hyperion DeFi” or the “Company”), today announced that it has acquired an additional 108,594 HYPE tokens, expanding its total holdings to 1,535,772 HYPE purchased at an average price of
This latest purchase is in preparation of deploying HYPE into Kinetiq’s iHYPE (“Institutional HYPE”) pool, a gated smart contract environment that provides access to the iHYPE Liquid Staking Token (LST). iHYPE is available only for select institutional participants that complete KYB/AML verification and compliance onboarding.
“Following the successful launch of our co-branded validator, we continued working closely with the Kinetiq team to begin implementing our HyperEVM DeFi strategy,” said Hyunsu Jung, Chief Investment Officer of Hyperion DeFi. “As the first public company to utilize Kinetiq’s institutional-grade liquid staking solution, we are taking key steps to provide shareholders with access to the unique opportunities only available on Hyperliquid.”
Hyperion DeFi expects to earn a passive staking yield while also unlocking capital efficiency with iHYPE, which can be used as collateral on the HyperEVM or with various offchain execution partners. Additionally, the Company will participate in Kinetiq’s ongoing kPoints incentive program, positioning it to play an ongoing role in the future growth of the Kinetiq ecosystem.
“The growing collaboration between Kinetiq and Hyperion is setting the standard for institutional engagement with Hyperliquid. As our launch partner for iHYPE, Hyperion continues to demonstrate a commitment to forward-thinking innovation in DeFi and we’re thrilled to work together to shape the future of onchain finance,” added Justin Greenberg, Co-Founder and Chief Technology Officer of Kinetiq.
This advancement supports Kinetiq’s long-term ambition to utilize Hyperliquid’s HIP-3 upgrade for an Exchange-as-a-Service offering supported by its cutting-edge staking infrastructure. Hyperion DeFi plans to continue its strategic participation in network growth initiatives available exclusively on Hyperliquid, with a focus on returning value to shareholders.
Investor Webinar
Management of Hyperion DeFi will host an investor webinar on Tuesday, July 29th, at 2:00pm ET to discuss the Company's bold transformation from a digital ophthalmic tech company into the first publicly listed U.S. firm focused on building a strategic treasury around HYPE, the native token of the high-performance Hyperliquid blockchain. A live question and answer session will follow the formal presentation.
Interested investors can register for the event here.
About the Hyperliquid Platform and the HYPE Token
Hyperliquid is a layer one blockchain (L1) optimized from the ground up for high frequency, transparent trading. The blockchain includes fully onchain perpetual futures and spot order books, with every order, cancel, trade, and liquidation occurring within 70 millisecond block times. It also hosts the HyperEVM, a general-purpose smart contract platform that, like Ethereum, supports permissionless decentralized financial applications.
HYPE is the native token of Hyperliquid. Staked HYPE in particular provides utility for users via reduced trading fees and increased referral bonuses. Circulating HYPE is autonomously purchased and sequestered by the blockchain itself with the trading fees generated on the network’s order books. As of June 2025, more than 25 million HYPE has been sequestered by this mechanism, and the token has become the 12th-largest cryptocurrency by market capitalization.
About Hyperion DeFi, Inc.
Hyperion DeFi, Inc. is the first U.S. publicly listed company building a long-term strategic treasury of Hyperliquid’s native token, HYPE. The Company is focused on providing its shareholders with simplified access to the Hyperliquid ecosystem, one of the fastest growing, highest revenue-generating blockchains in the world. Shareholders benefit from a gradually compounding exposure to HYPE, both from its native staking yield and additional revenues generated from its unique on-chain utility.
Hyperion DeFi is also developing its proprietary Optejet User Filled Device (UFD) that is designed to work with a variety of topical ophthalmic liquids, including artificial tears and lens rewetting products. The Optejet is especially useful in chronic front-of-the-eye diseases due to its ease of use, enhanced safety and tolerability, and potential for superior compliance versus standard eye drops. Together, these benefits may result in higher treatment compliance and better outcomes for patients and providers.
For more information, please visit Hyperiondefi.com.
About Kinetiq
The Kinetiq protocol is built natively on Hyperliquid to further staking initiatives around HYPE, the native token of the Hyperliquid blockchain, beginning with fully onchain, non-custodial liquid staking.
Kinetiq has become one of the fastest growing LSTs, amassing >
Forward Looking Statements
Except for historical information, all the statements, expectations and assumptions contained in this press release are forward-looking statements. Forward-looking statements include, but are not limited to, statements that express our intentions, beliefs, expectations, strategies, predictions or any other statements, our future activities or other future events or conditions, including the estimated market opportunities for our platform technology, the viability of, and risks associated with, our cryptocurrency treasury strategy, the clinical trials that may be necessary in connection with the clearance of the Optejet UFD, and the timing for sales growth of our approved products. These statements are based on current expectations, estimates and projections about our business based, in part, on assumptions made by management. These statements are not guarantees of future performance and involve risks, uncertainties and assumptions that are difficult to predict. Therefore, actual outcomes and results may, and in some cases are likely to, differ materially from what is expressed or forecasted in the forward-looking statements due to numerous factors discussed from time to time in documents which we file with the U.S. Securities and Exchange Commission.
In addition, such statements could be affected by risks and uncertainties related to, among other things: risks of our clinical trials, including, but not limited to, the potential advantages of our products, and platform technology; the rate and degree of market acceptance and clinical utility of our products; our estimates regarding the potential market opportunity for our products; reliance on third parties to develop and commercialize our products; the ability of us and our partners to timely develop, implement and maintain manufacturing, commercialization and marketing capabilities and strategies for our products; intellectual property risks; changes in legal, regulatory, legislative and geopolitical environments in the markets in which we operate and the impact of these changes on our ability to obtain regulatory approval for our products and product candidates; our competitive position; our ability to raise additional funds to maintain our business operations and to make payments on our debt obligations as and when necessary; and the risks of our cryptocurrency strategy as detailed in our Current Report on Form 8-K filed on June 27, 2025.
Any forward-looking statements speak only as of the date on which they are made, and except as may be required under applicable securities laws, Hyperion DeFi does not undertake any obligation to update any forward-looking statements.
Hyperion DeFi, Inc. Investor Contact:
Eric Ribner
LifeSci Advisors, LLC
eric@lifesciadvisors.com
(646) 751-4363
